Xstrata has been upgraded to buy from hold at RBS, target price rising to 1,050p from 625p. Evolution starts European big pharma coverage with buy for GlaxoSmithKline, sell for AstraZeneca. Robert Walters upped to buy from sell at KBC Peel Hunt, target increased to 250p from 70p. Morson upgraded to buy from hold at KBC Peel Hunt, TP rises to 150p from 65p. Northgate cut to hold from buy at Panmure Gordon, target price stays 26p. Ashmore upgraded to buy from neutral at UBS, target price rising to 275p from 220p. Booker initiated as buy at KBC Peel Hunt, target price 45p. United Business Media downgraded to hold from buy at RBS, target price falling to 475p from 500p. Story provided by Business Financial Newswire
|